Visit The Supreme Cannabis Company Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Supreme Cannabis Provides Investor Update Relating to the Legalization of Cannabis in Canada
- Supreme Cannabis to focus on the recreational market with its leading high-quality cannabis through its 7ACRES brand.
- Investment in world-class cultivation infrastructure, proprietary genetics and management systems, top tier corporate culture and high-quality cannabis flower is expected to lead to the innovation of high-quality products.
- Supreme Cannabis hires Steve Chan as VP of Investor Relations & Corporate Communications.
TORONTO, June 26, 2018 /CNW/ – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSXV: FIRE), applauds the Canadian federal government for the passage of the Cannabis Act (the “Act”) making Canada the first G7 country to legalize cannabis for adult recreational use. The Act received Royal Assent on June 21, 2018 and is expected to create a multi-billion-dollar legal consumer market with sales slated to commence as of October 17, 2018.
“The passage of the Cannabis Act is a victorious moment for cannabis policy in Canada, which occurred after decades of work and activism by multiple generations of cannabis advocates. I look forward to the commencement of our national recreational market, which will serve as a complement to and expansion of Canada’s current, world-leading medical cannabis regulations,” said John Fowler, CEO of Supreme Cannabis.
7ACRES National Recreational Brand
Upon legalization of recreational cannabis, Supreme Cannabis’ wholly-owned subsidiary 7ACRES’ will focus on the recreational market. To date, 7ACRES has been successful in selling to Licensed Producers under a business to business model and will now shift to selling directly to provincial distributors and retailers. 7ACRES has applied for retail listings in provinces across the country. The Company believes that 7ACRES is now one of the few nationally-renowned premium cannabis brands in Canada, as evidenced by its premium pricing model including its take-or-pay agreements priced at $6,000 per kilogram. Management believes 7ACRES is positioned to leverage its success in the medical market to now launch 7ACRES as a national high-quality consumer cannabis brand. Supreme Cannabis believes its focus on high-quality cannabis will allow the 7ACRES brand to continue receiving its premium pricing and generate favourable returns for the Company and its shareholders.
7ACRES is positioned as a brand that consumers will recognize on provincial shelves nationally. 7ACRES is committed to cultivate quality cannabis flower at scale and maintain a culture equally committed to this brand promise. In contrast to many of our peers, ahead of legalization we chose to take a deliberate approach to focus on the consumer and quality product versus a race-to-bottom approach focusing on cost-competition.
John Fowler, CEO of Supreme Cannabis
“Our market research suggests that, based on the US experience with legalization to-date, cannabis flower will be the leading product category in the recreational market. I believe our high-quality cannabis flower is attractive for Canadian cannabis flower consumers, particularly those who consume daily and weekly, which is a segment of the market that we anticipate will drive the bulk of the national dollar volume for flower sales. In addition, high-quality flower is the basis of and a necessary input to produce high-margin concentrate products which we anticipate being legal for production and sale in the coming years, subject to regulatory approval.”
Mr. Fowler continued, “To achieve our quality we have focused on quietly building our team, corporate culture, our world-class facility in Kincardine, and our management systems in order to grow product with premium aroma, visual appeal and flavour of our flower as we scale. In our view, in order for legal cannabis to replace the illicit market, the market must produce high-quality products to meet the demands of quality-focused consumers.”
7ACRES’ World Class Production Facility
Since 2013, 7ACRES has been developing proprietary growing methodology for producing high-quality cannabis flower for consumers focused on aroma and flavour. The 7ACRES growing facility is designed to operate as an indoor facility where plant growth is driven by double-ended HPS lighting and environmental parameters controlled by automated HVAC. Supreme Cannabis believes the 7ACRES facility produces a unique flower that bares many of the favourable characteristics of indoor-produced cannabis flower, with additional complexity in aroma and flavour produced by supplemental levels of natural sunlight.
7ACRES currently has three modular flowering rooms in operation with an anticipated annualized output of 5,000 kg. 7ACRES recently completed construction of three additional equally-sized flowering rooms which, subject to licensing, is anticipated to double 7ACRES annual output. Management anticipates construction of all 23 modular flowering rooms to be completed by December 2018. Once fully operational, management anticipates annual output of at least 50,000 kg per annum of high-quality cannabis flower.
“Supreme Cannabis has been focused on scaling production of high-quality flower since becoming licensed in March 2016. In our view, the modular strategy driving our 7ACRES expansion de-risks the scaling of our operations while maintaining our reputation for high-end quality and supports our quality-based brand promise. As one of the newest publicly-listed Licensed Producers, we are one of the fastest scaling and have generated approximately $5.3 million of revenue in the first 9 months of revenue,” said Mr. Fowler.
Culture of Quality, Success and Empowerment
Management takes pride in the development of quality-driven corporate culture at 7ACRES. Supreme Cannabis believes culture is a direct contributor to the quality of 7ACRES’ cannabis flower and quality product innovation starts with quality flower and people. Investors and other stakeholders such as existing customers, retailers and provincial buyers who have toured the Company’s 7ACRES facilities in Kincardine have been struck by the quality, motivation and enthusiasm of the 7ACRES team. Supreme Cannabis fosters this culture based on a clear mission for 7ACRES to be the leading brand for high-end cannabis flower, which has allowed the Company to attract and retain top operational talent and also focus on the development and innovation of high-end concentrate products. Further, management believes corporate culture will be an important element to establishing 7ACRES as an authentic consumer brand with a mission to produce beautiful cannabis products for cannabis enthusiasts whose purchasing will be driven by quality.
In addition, Supreme Cannabis has been actively building its management team to support its consumer and medical business development. Supreme Cannabis has retained top talent from the alcohol, agriculture and pharmaceutical Industries.
VP of Investor Relations and Corporate Communications
Supreme Cannabis is also pleased to announce the addition of Mr. Steve Chan, as Vice President, Investor Relations & Corporate Communications. Mr. Chan was most recently a Principal of Hugessen Consulting in Toronto, Ontario. For over a decade, Mr. Chan has served as a trusted advisor to boards and senior management teams across North America, advising on complex strategic performance, governance, and shareholder interests. Mr. Chan has worked closely with global institutional investors, pension and sovereign wealth funds, private equity, and major family offices. He has worked with major public and private, including companies in high growth sectors and regulated industries. Previously, Mr. Chan was a capital markets strategist at TD Securities.
The Company granted 400,000 stock options (each an “Option”) to Mr. Chan pursuant to the Company’s Amended and Restated Incentive Stock Option Plan (the “Plan”). Each Option has an exercise price of $1.70 and is exercisable into one common share, subject to certain vesting conditions and the terms and conditions of the Plan, and expire on June 25, 2023.
About Supreme Cannabis
Supreme Cannabis is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of cannabis pursuant to the ACMPR operating inside a 342,000 sq. ft. Hybrid Facility. The Hybrid Facility combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint. Please visit www.supreme.ca and www.7ACRES.com for more information.
For fact-based information on The Supreme Cannabis Company, view the company’s sponsored Investor Dashboard.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.